142 related articles for article (PubMed ID: 25811668)
1. Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange Program.
Falorni A; Bini V; Betterle C; Brozzetti A; Castaño L; Fichna M; Kämpe O; Mellgren G; Peterson P; Chen S; Rönnelid J; Seissler J; Tiberti C; Uibo R; Yu L; Lernmark Å; Husebye E
Clin Chem Lab Med; 2015 Oct; 53(11):1761-70. PubMed ID: 25811668
[TBL] [Abstract][Full Text] [Related]
2. Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies.
Falorni A; Chen S; Zanchetta R; Yu L; Tiberti C; Bacosi ML; Furmaniak J; Bini V; Dotta F; Eisenbarth GS; Smith BR; Betterle C
Clin Immunol; 2011 Sep; 140(3):291-9. PubMed ID: 21570358
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.
Brozzetti A; Marzotti S; La Torre D; Bacosi ML; Morelli S; Bini V; Ambrosi B; Giordano R; Perniola R; De Bellis A; Betterle C; Falorni A;
Eur J Endocrinol; 2010 Aug; 163(2):309-17. PubMed ID: 20498138
[TBL] [Abstract][Full Text] [Related]
4. A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain of human steroid 21-hydroxylase.
Nikoshkov A; Falorni A; Lajic S; Laureti S; Wedell A; Lernmark K; Luthman H
J Immunol; 1999 Feb; 162(4):2422-6. PubMed ID: 9973524
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
de Carmo Silva R; Kater CE; Dib SA; Laureti S; Forini F; Cosentino A; Falorni A
Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
[TBL] [Abstract][Full Text] [Related]
6. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease.
Laureti S; De Bellis A; Muccitelli VI; Calcinaro F; Bizzarro A; Rossi R; Bellastella A; Santeusanio F; Falorni A
J Clin Endocrinol Metab; 1998 Oct; 83(10):3507-11. PubMed ID: 9768655
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.
Silva RC; Sallorenzo C; Kater CE; Dib SA; Falorni A
Diabetes Nutr Metab; 2003 Jun; 16(3):160-8. PubMed ID: 14635733
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1.
Bøe AS; Bredholt G; Knappskog PM; Hjelmervik TO; Mellgren G; Winqvist O; Kämpe O; Husebye ES
Eur J Endocrinol; 2004 Jan; 150(1):49-56. PubMed ID: 14713279
[TBL] [Abstract][Full Text] [Related]
10. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.
Falorni A; Laureti S; Nikoshkov A; Picchio ML; Hallengren B; Vandewalle CL; Gorus FK; Tortoioli C; Luthman H; Brunetti P; Santeusanio F
Clin Exp Immunol; 1997 Feb; 107(2):341-6. PubMed ID: 9030873
[TBL] [Abstract][Full Text] [Related]
11. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay.
Tanaka H; Perez MS; Powell M; Sanders JF; Sawicka J; Chen S; Prentice L; Asawa T; Betterle C; Volpato M; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1997 May; 82(5):1440-6. PubMed ID: 9141530
[TBL] [Abstract][Full Text] [Related]
12. Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.
Falorni A; Laureti S; De Bellis A; Zanchetta R; Tiberti C; Arnaldi G; Bini V; Beck-Peccoz P; Bizzarro A; Dotta F; Mantero F; Bellastella A; Betterle C; Santeusanio F;
J Clin Endocrinol Metab; 2004 Apr; 89(4):1598-604. PubMed ID: 15070918
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease--an association study and expression analysis.
Fichna M; Żurawek M; Bratland E; Husebye ES; Kasperlik-Załuska A; Czarnocka B; Januszkiewicz-Lewandowska D; Nowak J
Autoimmunity; 2015 Mar; 48(2):100-7. PubMed ID: 25347332
[TBL] [Abstract][Full Text] [Related]
14. A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease.
Volpato M; Prentice L; Chen S; Betterle C; Rees Smith B; Furmaniak J
Clin Exp Immunol; 1998 Feb; 111(2):422-8. PubMed ID: 9486414
[TBL] [Abstract][Full Text] [Related]
15. The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease.
Wolff AB; Breivik L; Hufthammer KO; Grytaas MA; Bratland E; Husebye ES; Oftedal BE
Eur J Endocrinol; 2021 Apr; 184(4):607-615. PubMed ID: 34665570
[TBL] [Abstract][Full Text] [Related]
16. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.
Betterle C; Volpato M; Pedini B; Chen S; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1999 Feb; 84(2):618-22. PubMed ID: 10022426
[TBL] [Abstract][Full Text] [Related]
17. Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies.
Baker PR; Nanduri P; Gottlieb PA; Yu L; Klingensmith GJ; Eisenbarth GS; Barker JM
Clin Endocrinol (Oxf); 2012 May; 76(5):617-24. PubMed ID: 22066755
[TBL] [Abstract][Full Text] [Related]
18. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.
Bratland E; Bredholt G; Mellgren G; Knappskog PM; Mozes E; Husebye ES
J Autoimmun; 2009 Aug; 33(1):58-67. PubMed ID: 19329278
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease.
Song YH; Connor EL; Muir A; She JX; Zorovich B; Derovanesian D; Maclaren N
J Clin Endocrinol Metab; 1994 May; 78(5):1108-12. PubMed ID: 7513715
[TBL] [Abstract][Full Text] [Related]
20. 21-hydroxylase autoantibody-negative Addison's disease in a 5-year-old boy with adrenal crisis and type 1 diabetes mellitus.
Chang JT; Chen YY; Chiu PC
J Pediatr Endocrinol Metab; 2010 Nov; 23(11):1201-5. PubMed ID: 21284337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
